Clinical Trials Browser

Phase 1/2 × Prostatic Neoplasms × sargramostim × Clear all

NCT01784913 2024-12-16

UV1/hTERT2012P

Phase 1/2 Completed

Neoplasms, Prostatic Neoplasms

NCT00939510 2013-01-31

Lenalidomide and GM-CSF in Treating Patients With Prostate Cancer

Phase 1/2 Completed

32 enrolled 9 charts

Prostatic Neoplasms